Story of Influenza Antivirals: Part 30

The claimed effect on prophylaxis, pre-and post-exposure

Another key claim made by researchers and manufacturers was that prophylactic oseltamivir and zanamivir could, if taken soon after or before contact with an influenza case, prevent spread. Roche, after the launch of oseltamivir, claimed that the drug did not prevent infection in healthy people but rather stopped the newly formed virions from budding fro…